Response by Kuwabara et al to Letter Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial"
- PMID: 32078428
- DOI: 10.1161/CIRCULATIONAHA.120.045318
Response by Kuwabara et al to Letter Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial"
Comment on
-
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial.Circulation. 2019 Sep 17;140(12):992-1003. doi: 10.1161/CIRCULATIONAHA.118.039415. Epub 2019 Aug 22. Circulation. 2019. PMID: 31434507 Clinical Trial.
-
Letter by Weingärtner et al Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial".Circulation. 2020 Feb 11;141(6):e65-e66. doi: 10.1161/CIRCULATIONAHA.119.043726. Epub 2020 Feb 10. Circulation. 2020. PMID: 32078427 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical